The Jeannie Ferris Cancer Australia Recognition Award was established by Cancer Australia in 2013, to recognise outstanding contribution to improving outcomes for women with gynaecological cancers.
Jeannie Ferris Cancer Australia Recognition Award
The Jeannie Ferris Cancer Australia Recognition Award is named in honour of the late Jeannie Ferris, Senator for South Australia, who was passionately committed to raising awareness about gynaecological cancers. Senator Ferris was diagnosed with ovarian cancer in October 2005 and passed away in April 2007.
The Award recognises outstanding contribution to improving outcomes for women with gynaecological cancers by people in two categories:
Category 1 : Member of the community
Those with a personal experience of gynaecological cancer either as a woman with a diagnosis of gynaecological cancer, or as a community member, family member or carer who has made an exceptional contribution to supporting women affected by gynaecological cancer; andhealth professionals or researchers working in the area of gynaecological cancers.
Category 2: Health professional/researcher
Health professionals or researchers working in the area of gynaecological cancers.
Cancer Australia is pleased to announce the 2016 recipients of the Jeannie Ferris Cancer Australia Recognition Award:
Category 1: Ms Karen Livingstone
Ms Karen Livingstone won the Award for her ongoing advocacy work in gynaecological cancer, consumer support and research.
Karen, whose mother died of ovarian cancer, was a co-founder of Ovarian Cancer Australia in 2001 and in 2009 she established national Ovarian Cancer Awareness Month to raise awareness in the community of ovarian cancer.
As a consumer representative on the Australia New Zealand Gynaecological Oncology Group (ANZGOG), Karen actively fostered consumer engagement in cancer clinical trials. Karen has also been a driving force in the development of the innovative research program, the OASIS initiative.
Category 2: Professor Michael Quinn AM
Professor Quinn is highly regarded nationally and internationally for his leadership in gynaecological cancer, as a respected gynaecological oncologist, researcher and innovator. Professor Quinn co-founded ANZGOG in 2000 and was Chair from 2009 until 2012. He has held a number of key positions internationally including, chair of Gynaecologic Cancer Intergroup (the world’s largest gynaecological cancer clinical trials group) from 2010-2012, and he is currently President of the International Gynaecologic Cancer Society.
Professor Quinn has authored more than 255 refereed publications, 5 text books, 13 book chapters and 3 monographs. He serves as a Senior Editor of the International Journal of Gynaecological Oncology.
Category 1: Ms Bridget Whelan
Category 2: Professor Michael Friedlander AM
Category 1: Ms Kath Mazzella OAM
Category 2: Professor David Bowtell
Category 1: Mr Simon Lee
Category 2: Professor Neville Hacker AM